BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7488387)

  • 1. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
    Wang T; Lasota J; Hanau CA; Miettinen M
    APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 is consistently expressed in hyperplastic marginal zones of the spleen, abdominal lymph nodes, and ileal lymphoid tissue.
    Meda BA; Frost M; Newell J; Bohling SD; Huebner-Chan DR; Perkins SL; Lim MS; Medeiros LJ; Elenitoba-Johnson KS
    Am J Surg Pathol; 2003 Jul; 27(7):888-94. PubMed ID: 12826880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias.
    Triscott JA; Ritter JH; Swanson PE; Wick MR
    J Cutan Pathol; 1995 Feb; 22(1):2-10. PubMed ID: 7751474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
    Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
    Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
    Alkan S; Ross CW; Hanson CA; Schnitzer B
    Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous B cell processes with nodular pattern].
    Chirife AM; Bilbao ER; Giménez L; Marino L
    Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction for bcl-2 in diagnostic lymph node biopsies.
    Said JW; Sassoon AF; Shintaku IP; Corcoran P; Nichols SW
    Mod Pathol; 1990 Nov; 3(6):659-63. PubMed ID: 2263590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 gene rearrangements in primary B-cell lymphoma of the gastrointestinal tract reveal follicular lymphoma as a subtype.
    Straka C; Mielke B; Eichelmann A; Trede I; Ho AD; Möller P
    Leukemia; 1993 Feb; 7(2):268-73. PubMed ID: 8426481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin cells accumulate mRNA for bcl-2.
    Hell K; Lorenzen J; Fischer R; Hansmann ML
    Lab Invest; 1995 Oct; 73(4):492-6. PubMed ID: 7474920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
    Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms.
    Zutter M; Hockenbery D; Silverman GA; Korsmeyer SJ
    Blood; 1991 Aug; 78(4):1062-8. PubMed ID: 1868240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
    Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
    Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal benign and malignant monocytoid B cells with and without follicular lymphomas: a comparative study of follicular colonization, light chain restriction, bcl-2, and t(14;18) in 39 cases.
    Hernandez AM; Nathwani BN; Nguyen D; Shibata D; Chuan W; Nichols P; Taylor CR
    Hum Pathol; 1995 Jun; 26(6):625-32. PubMed ID: 7774892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.